The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
1d
Zacks.com on MSNCHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's ImfinziJohnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...
2d
Zacks.com on MSNBiogen Stock Down on Regulatory Update in the EU for Alzheimer's DrugBiogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy ...
The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...
Johnson & Johnson’s subcutaneous form of Rybrevant has been recommended for approval by the European Medicines Agency’s human ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...
The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...
Merck Receives Positive EU CHMP Opinion for CAPVAXIVEâ„¢ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results